Kazia Therapeutics (KZIA) Payables (2009 - 2025)
Kazia Therapeutics (KZIA) posted Payables of $6.4 million for Q4 2025, down 4.94% on a QoQ basis from $6.7 million in Q2 2025, and down 7.68% year-over-year from $6.9 million in Q4 2024.
Kazia Therapeutics (KZIA) Payables (2009 - 2025) Analysis & Trends
Kazia Therapeutics' Payables history runs 17 years deep, the most recent figure standing at $6.4 million for Q4 2025.
- Quarterly Payables fell 7.68% year-over-year to $6.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.4 million (down 7.68% YoY) and the FY2025 annual result came in at $6.7 million, down 34.94% from the prior year.
- Payables was $6.4 million for Q4 2025 at Kazia Therapeutics, down from $6.7 million in the prior quarter.
- Across five years, Payables topped out at $10.3 million in Q2 2024 and bottomed at $1.4 million in Q2 2022.
- A 5-year average of $5.1 million and a median of $4.4 million in 2021 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables plunged 63.83% — and 2023, when it soared 197.98%.
- Kazia Therapeutics' Payables stood at $4.8 million in 2021, then sank by 48.97% to $2.4 million in 2022, then surged by 69.89% to $4.1 million in 2023, then soared by 67.8% to $6.9 million in 2024, then decreased by 7.68% to $6.4 million in 2025.
- Business Quant data shows KZIA's Payables at $6.4 million in Q4 2025, $6.7 million in Q2 2025, and $6.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | 6.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.40 Mn |
| Jun 30, 2025 | 6.73 Mn |
| Dec 31, 2024 | 6.93 Mn |
| Jun 30, 2024 | 10.35 Mn |
| Dec 31, 2023 | 4.13 Mn |
| Jun 30, 2023 | 4.09 Mn |
| Dec 31, 2022 | 2.43 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Dec 31, 2021 | 4.77 Mn |
| Jun 30, 2021 | 3.80 Mn |
| Dec 31, 2020 | 1.84 Mn |
| Jun 30, 2020 | 2.29 Mn |
| Dec 31, 2019 | 2.01 Mn |
| Jun 30, 2019 | 1.24 Mn |
| Dec 31, 2018 | 1.65 Mn |
| Jun 30, 2018 | 1.56 Mn |
| Jun 30, 2017 | 1.41 Mn |
| Dec 31, 2016 | 2.09 Mn |
| Jun 30, 2016 | 1.40 Mn |
| Dec 31, 2015 | 1.17 Mn |